116 related articles for article (PubMed ID: 8822366)
1. Compartment analysis of cerebral glucose metabolism and in vitro glucose-metabolizing enzyme activities in the rat brain.
Ouchi Y; Fukuyama H; Matsuzaki S; Ogawa M; Kimura J; Tsukada H; Kakiuchi T; Kosugi T; Nishiyama S
Brain Res; 1996 Jan; 706(2):267-72. PubMed ID: 8822366
[TBL] [Abstract][Full Text] [Related]
2. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
3. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic projection from the basal forebrain and cerebral glucose metabolism in rats: a dynamic PET study.
Ouchi Y; Fukuyama H; Ogawa M; Yamauchi H; Kimura J; Magata Y; Yonekura Y; Konishi J
J Cereb Blood Flow Metab; 1996 Jan; 16(1):34-41. PubMed ID: 8530553
[TBL] [Abstract][Full Text] [Related]
5. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling between cortical glucose metabolism and blood flow after ibotenate lesion of the rat basal forebrain: a PET study.
Ogawa M; Fukuyama H; Ouchi Y; Yamauchi H; Matsuzaki S; Kimura J; Tsukada H
Neurosci Lett; 1996 Feb; 204(3):193-6. PubMed ID: 8938263
[TBL] [Abstract][Full Text] [Related]
7. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
Roelcke U; Kappos L; Lechner-Scott J; Brunnschweiler H; Huber S; Ammann W; Plohmann A; Dellas S; Maguire RP; Missimer J; Radü EW; Steck A; Leenders KL
Neurology; 1997 Jun; 48(6):1566-71. PubMed ID: 9191767
[TBL] [Abstract][Full Text] [Related]
8. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
[TBL] [Abstract][Full Text] [Related]
9. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
Kuwabara H; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
[TBL] [Abstract][Full Text] [Related]
10. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
11. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
[TBL] [Abstract][Full Text] [Related]
12. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
[TBL] [Abstract][Full Text] [Related]
13. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares).
Uehara S; Kuwabara Y; Ichiya Y; Otsuka M; Ayabe Y; Miyake Y; Masuda K; Yoshimura A
Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics of glucose metabolism in central neurocytomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Oct; 47(10):981-7. PubMed ID: 7577144
[TBL] [Abstract][Full Text] [Related]
15. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
Miyazawa H; Osmont A; Petit-Taboué MC; Tillet I; Travère JM; Young AR; Barré L; MacKenzie ET; Baron JC
J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Okazumi S; Isono K; Enomoto K; Kikuchi T; Ozaki M; Yamamoto H; Hayashi H; Asano T; Ryu M
J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
[TBL] [Abstract][Full Text] [Related]
19. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
20. [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Enomoto K; Fukunaga T; Okazumi S; Asano T; Kikuchi T; Yamamoto H; Nagashima T; Isono K; Itoh H; Imazeki K
Kaku Igaku; 1991 Nov; 28(11):1353-6. PubMed ID: 1663176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
